With the increasing acceptance of medical cannabis, Rutgers Health researchers are investigating its potential effects on patients' physical and mental health. The five-year study, supported by a $686,376 grant from the National Institute on Drug Abuse, aims to explore both the therapeutic benefits and possible health risks associated with medical cannabis use.
The research will focus on the risk of developing cannabis use disorder (CUD), a condition characterized by a problematic pattern of cannabis consumption. Previous studies suggest that nearly 20% of individuals using medical cannabis for three months may develop CUD, experiencing increased tolerance and dependence.
“There’s been a rapid expansion of medical cannabis use, but we lack clarity related to potential risks,” said Tammy Chung, the lead researcher and psychiatry professor at the Rutgers Institute for Health, Health Care Policy and Aging Research. She highlighted the need for clearer criteria in assessing CUD among therapeutic and recreational users and emphasized the importance of understanding these factors to inform healthcare decisions.
Chung noted that while symptoms like paranoia and memory loss are associated with CUD, escalating tolerance is an immediate concern as it can lead to higher costs and increased consumption. “It’s important to note that not all patients using medical cannabis develop CUD,” she said. However, identifying those at risk remains uncertain.
To participate in the study, individuals must meet New Jersey's legal qualifications for cannabis use and possess a valid medicinal cannabis program card authorizing therapeutic use.
